Summary
For Year 2025-26, Divi's Laboratories reports the following shareholding: Total Promoters at 51.88%, Mutual Fund at 13.73%, Insurance at 4.92%, Foreign Institutional Investors at 20.08%, Domestic Institutional Investors at 0.62%, and Retail at 8.76%. This breakdown provides a quick snapshot of ownership distribution for Divi's Laboratories in 2025-26.
Divi's Laboratories FAQs
As of 03-2026, the promoter shareholding in Divi's Laboratories stands at 51.88% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Divi's Laboratories is 20.08% and 0.62% respectively.
The retail shareholding of the Divi's Laboratories is 8.76%.
Changes in shareholding patterns of Divi's Laboratories can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Divi's Laboratories are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Divi's Laboratories Associated Pages
